Allez à nos transactions
Placements Privés | Soins de la Santé

AllCare has received a growth investment from Summit Partners

AllCare Family Medicine & Urgent Care (AllCare) has received a growth investment from Summit Partners.

AllCare is a provider of tech-enabled primary care medical services in retail-based settings.

Summit Partners is a private equity firm based in Boston, Massachusetts. The firm focuses on investing in technology, healthcare, life sciences and other growth industries.

Oaklins’ team in Los Angeles acted as the exclusive advisor to seller in this transaction.

Parties prenantes

Contacter l'équipe de la transaction

Adam Abramowitz

Directeur général
Los Angeles, États-Unis
Oaklins Intrepid

Kyle Berkman

Directeur associé
Los Angeles, États-Unis
Oaklins Intrepid

Gavin Cutrino

Analyste senior
Los Angeles, États-Unis
Oaklins Intrepid

Transactions connexes

UKAT Group has acquired Bayberry Limited
Placements Privés | Soins de la Santé

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

En apprendre plus
Medicija has acquired Saulės Šeimos Medicinos Centras
Soins de la Santé

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

En apprendre plus
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Soins de la Santé

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

En apprendre plus